Healthcare and Life Sciences Deal Activity Will Be Robust in 2021: KPMG Survey
The FINANCIAL-- Volume of deals rises 15% aided by late 2020 surge, despite pandemic -- Growing valuations seen in biopharma, ...
The FINANCIAL-- Volume of deals rises 15% aided by late 2020 surge, despite pandemic -- Growing valuations seen in biopharma, ...